Literature DB >> 15229861

Enrichment of presynaptic and postsynaptic markers by size-based gating analysis of synaptosome preparations from rat and human cortex.

Karen H Gylys1, Jeffrey A Fein, Fusheng Yang, Gregory M Cole.   

Abstract

BACKGROUND: Synapse regions in the brain are difficult to isolate and study; resealed nerve terminals (synaptosomes) are a widely used in vitro system for the study of neurotransmission, but nonsynaptosomal elements in the homogenate complicate data interpretation. With the goal of quantitative analysis of pathways leading to synapse loss in neurodegenerative disease, we have developed a method that allows focus on the intact synaptosomes within a crude synaptosomal preparation by gating the largest particles based on forward angle light scatter (FSC).
METHODS: Crude synaptosomal fractions (P-2) were prepared and labeled with a viability dye (calcein AM), a presynaptic marker (SNAP-25), and a postsynaptic marker (PSD-95). Forward scatter gates based on size standards were drawn to identify the large population (1.4-4.5 microm), and the enrichment of each marker was quantified in preparations from fresh rat homogenates and from cryopreserved human cortex.
RESULTS: Gating on forward scatter resulted in an increase that was highly significant (P < 0.001) for all three markers examined. The calcein-AM-positive fraction in the large synaptosomes was 98% +/- 0.8, and 75% +/- 9.8 for rat and human, respectively. Of large particles, 90% +/- 2.7 in rat and 82% +/- 2.6 in human were positive for SNAP-25, indicating a relatively pure population of intact synaptosomes. A total of 76% +/- 2.9 of the large particles were positive for PSD-95 in rat. This compared to 36% +/- 3.0 in human tissue, and indicates that both presynaptic and postsynaptic elements may be analyzed with this methodology.
CONCLUSIONS: Most nonsynaptosomal elements can be excluded and the intact subpopulation of interest within the P-2 can be identified based on size. Size-based gating analysis provides a simple and cost-effective method to monitor fluorescence changes in synapse regions. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229861     DOI: 10.1002/cyto.a.20031

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  24 in total

1.  Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.

Authors:  Sophie Sokolow; Kristen M Henkins; Tina Bilousova; Bianca Gonzalez; Harry V Vinters; Carol A Miller; Lindsey Cornwell; Wayne W Poon; Karen H Gylys
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

2.  Preparation of synaptoneurosomes from mouse cortex using a discontinuous percoll-sucrose density gradient.

Authors:  Pamela R Westmark; Cara J Westmark; Athavi Jeevananthan; James S Malter
Journal:  J Vis Exp       Date:  2011-09-17       Impact factor: 1.355

3.  Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex.

Authors:  Sophie Sokolow; Sanh H Luu; Karabi Nandy; Carol A Miller; Harry V Vinters; Wayne W Poon; Karen H Gylys
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

4.  Pharmacological Rescue of Long-Term Potentiation in Alzheimer Diseased Synapses.

Authors:  G Aleph Prieto; Brian H Trieu; Cindy T Dang; Tina Bilousova; Karen H Gylys; Nicole C Berchtold; Gary Lynch; Carl W Cotman
Journal:  J Neurosci       Date:  2016-12-16       Impact factor: 6.167

5.  Flow Cytometry Analysis and Quantitative Characterization of Tau in Synaptosomes from Alzheimer's Disease Brains.

Authors:  Karen Hoppens Gylys; Tina Bilousova
Journal:  Methods Mol Biol       Date:  2017

6.  Isolation of synaptic terminals from Alzheimer's disease cortex.

Authors:  Sophie Sokolow; Kristen M Henkins; Iris A Williams; Harry V Vinters; Ingrid Schmid; Gregory M Cole; Karen H Gylys
Journal:  Cytometry A       Date:  2011-12-28       Impact factor: 4.355

7.  Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.

Authors:  Tina Bilousova; Mikhail Melnik; Emily Miyoshi; Bianca L Gonzalez; Wayne W Poon; Harry V Vinters; Carol A Miller; Maria M Corrada; Claudia Kawas; Asa Hatami; Ricardo Albay; Charles Glabe; Karen H Gylys
Journal:  Am J Pathol       Date:  2019-05-17       Impact factor: 4.307

8.  Proteomic screening of glutamatergic mouse brain synaptosomes isolated by fluorescence activated sorting.

Authors:  Christoph Biesemann; Mads Grønborg; Elisa Luquet; Sven P Wichert; Véronique Bernard; Simon R Bungers; Ben Cooper; Frédérique Varoqueaux; Liyi Li; Jennifer A Byrne; Henning Urlaub; Olaf Jahn; Nils Brose; Etienne Herzog
Journal:  EMBO J       Date:  2014-01-10       Impact factor: 11.598

9.  AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly.

Authors:  Sophie Sokolow; Kristen M Henkins; Tina Bilousova; Carol A Miller; Harry V Vinters; Wayne Poon; Gregory M Cole; Karen Hoppens Gylys
Journal:  Neurobiol Aging       Date:  2011-07-07       Impact factor: 4.673

10.  Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases.

Authors:  Tina Bilousova; Carol A Miller; Wayne W Poon; Harry V Vinters; Maria Corrada; Claudia Kawas; Eric Y Hayden; David B Teplow; Charles Glabe; Ricardo Albay; Gregory M Cole; Edmond Teng; Karen H Gylys
Journal:  Am J Pathol       Date:  2016-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.